Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact Of Platelet Function Inhibition On Circulating Cancer Cells In Metastatic Breast Cancer Patients

NCT00263211 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00263211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00263211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact Of Platelet Function Inhibition On Circulating Cancer Cells In Metastatic Breast Cancer Patients
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2006
Completion date
September 30, 2009
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms